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Statistical prediction of immunity 
to placental malaria based on multi-assay 
antibody data for malarial antigens
Chathura Siriwardhana1†, Rui Fang1†, Ali Salanti2, Rose G. F. Leke3, Naveen Bobbili4, Diane Wallace Taylor4 
and John J. Chen1* 
Abstract 
Background: Plasmodium falciparum infections are especially severe in pregnant women because infected eryth-
rocytes (IE) express VAR2CSA, a ligand that binds to placental trophoblasts, causing IE to accumulate in the placenta. 
Resulting inflammation and pathology increases a woman’s risk of anemia, miscarriage, premature deliveries, and 
having low birthweight (LBW) babies. Antibodies (Ab) to VAR2CSA reduce placental parasitaemia and improve preg-
nancy outcomes. Currently, no single assay is able to predict if a woman has adequate immunity to prevent placental 
malaria (PM). This study measured Ab levels to 28 malarial antigens and used the data to develop statistical models for 
predicting if a woman has sufficient immunity to prevent PM.
Methods: Archival plasma samples from 1377 women were screened in a bead-based multiplex assay for Ab to 17 
VAR2CSA-associated antigens (full length VAR2CSA (FV2), DBL 1-6 of the FCR3, 3D7 and 7G8 lines, ID1-ID2a (FCR3 and 
3D7) and 11 antigens that have been reported to be associated with immunity to P. falciparum (AMA-1, CSP, EBA-175, 
LSA1, MSP1, MSP2, MSP3, MSP11, Pf41, Pf70 and RESA)). Ab levels along with clinical variables (age, gravidity) were 
used in the following seven statistical approaches: logistic regression full model, logistic regression reduced model, 
recursive partitioning, random forests, linear discriminant analysis, quadratic discriminant analysis, and support vector 
machine.
Results: The best and simplest model proved to be the logistic regression reduced model. AMA-1, MSP2, EBA-175, 
Pf41, and MSP11 were found to be the top five most important predictors for the PM status based on overall predic-
tion performance.
Conclusions: Not surprising, significant differences were observed between PM positive (PM+) and PM negative 
(PM−) groups for Ab levels to the majority of malaria antigens. Individually though, these malarial antigens did not 
achieve reasonably high performances in terms of predicting the PM status. Utilizing multiple antigens in predictive 
models considerably improved discrimination power compared to individual assays. Among seven different classifiers 
considered, the reduced logistic regression model produces the best overall predictive performance.
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Background
Plasmodium falciparum infections in pregnant women 
increases the risk of maternal anaemia, spontaneous 
abortions, premature deliveries, and low birthweight 
(LBW) babies, because infected erythrocytes (IE) seques-
ter in the intervillous space (IVS) of the placenta caus-
ing placental malaria (PM). Sequestration is mediated 
by the binding of the malarial antigen VAR2CSA on 
the surface of IE with chondroitin sulfate A on tropho-
blasts lining the IVS. Over several pregnancies, women 
in malaria-endemic areas can produce antibodies (Ab) 
to VAR2CSA-expressing IE that are associated with 
improved pregnancy outcomes, e.g., reduced prevalence 
of maternal anaemia [1, 2], lower placental parasitaemias 
[3–5], decreased prevalence of LBW babies [6], improved 
infant birthweights [2, 7] and lower risk of drug-treat-
ment failures [1]. Thus, Ab to VAR2CSA play a significant 
role in immunity against PM; however, no single Ab test 
or method is available to determine if a woman has suf-
ficient immunity to prevent PM.
Serological correlates of protection for Ab to 
VAR2CSA have been sought. VAR2CSA consists of six 
Duffy Binding-Like (DBL) domains and several inter-
spersed domains [8–10]. Each of the six domains and Ab 
to full length VAR2CSA (FV2) have been implicated in 
protection [9–15], but Ab levels to FV2 or a single DBL 
domain alone is not adequate to determine if a woman is 
protected from PM. Developers of VAR2CSA-based vac-
cine have employed functional tests to measure the abil-
ity of Ab to inhibit the binding of IE to CSA, but it has 
been difficult to link inhibition of binding activity with 
absence of PM in women living in malaria endemic areas. 
In a high malaria transmission area, the absence of PM 
at delivery was found to correlate with high Ab levels to 
FV2 at 5  months of pregnancy (P =  0.005); Ab to mul-
tiple DBL domains and allelic variants (P =  0.003), and 
proportion of high avidity Ab to FV2 (P =  0.0009) [16, 
17]. Similarly, in an urban area, when 420 plasma samples 
from multigravid women collected at delivery screened 
in 21 serological assays for Ab to FV2, different DBL vari-
ants, and Ab avidity to FV2, the only immune parameter 
that correlated with protection was proportion of high 
avidity Ab [18]. In the study, a 5% increase in proportion 
of high avidity Ab was associated with nearly a 15% lower 
likelihood of PM. Thus, some correlates of protection 
exist, but none are robust enough to accurately predict 
the PM immune status of pregnant women.
Analytical tools that help predict if women have 
acquired protective immunity to PM are needed. The 
availability of a cost-effective diagnostic approach to 
identify a woman’s level of immunity would allow (1) 
doctors to provide better prenatal care, (2) vaccine devel-
opers to assess the level of immunity women have before 
and after vaccination, and (3) government officials to 
make intelligent health policies for pregnant women. 
Because immunity to P. falciparum infections is com-
plex, few attempts have been made to develop predictive 
models of immunity [19, 20]. However, since immunity to 
PM is thought to be mediated by Ab to a single malarial 
antigen, it may be possible to develop predictive models. 
This study evaluates the hypothesis that using a compre-
hensive multiple-assay approach will lead to improved 
predictive power. In the current study, plasma collected 
at delivery from 1377 pregnant women with and with-
out PM were screened in 28 serological assays for IgG to 
FV2 and different lines of the six DBL domains, as well 
as, eleven Ab to antigens associated with malarial immu-
nity (AMA-1, CSP, EBA-175, LSA1, MSP1, MSP2, MSP3, 
MSP11, Pf41, Pf70 and RESA). Multivariable logistic 
regression and five other statistical classification methods 
were used to determine the optimal number of assays, 
along with other clinical variables such as age and gravid-
ity, to provide the best prediction model.
Methods
Ethical approvals
De-identified, archival plasma samples used in the cur-
rent study were exempt from human subject research by 
the Committee on Human Studies, University of Hawaii, 
Manoa (CHS#21891). The original study was approved 
by the National Ethics Committee, Cameroon and the 
Institutional Review Board at Georgetown University, 
and participants gave written informed consent to use 
their blood to study Ab to malaria.
Study design and plasma samples
Archival plasma samples from a cross-sectional study 
conducted between 1996 and 2001 [21, 22] in Yaoundé, 
Cameroon were used. Details on study site, enrollment 
criteria, sample collection, and laboratory tests are 
reported in Tako et al. [22]. Yaoundé is a malaria endemic 
area where the entomological inoculation rates were esti-
mated to be 13 infectious bites per person per year at the 
time the samples were collected [23, 24]. In the initial 
study, pregnant women were enrolled at the Biyem-Assi 
Hospital, a district hospital that mainly cares for women 
in the surrounding area, and the Central Maternity Hos-
pital, a referral hospital for a diverse group of women 
[22]. An advantage of using clinical data and plasma from 
this cohort is that the study was conducted before imple-
mentation in 2004 of intermittent preventive treatment 
(IPT). Thus, women in the study developed naturally-
acquired immunity to PM that aided in clearing their 
placental infections. Post-IPT implementation, placental 
parasitaemias are prevented by the use of sulfadoxine–
pyrimethamine, making it impossible to assess the role 
Page 3 of 12Siriwardhana et al. Malar J  (2017) 16:391 
of naturally acquired immunity. Women were not tested 
for HIV; however, the prevalence of HIV among pregnant 
women attending antenatal-clinics in Yaoundé at the 
time was 4.0–13.6% [25], making it unlikely HIV infec-
tions had a major impact on the study.
Women were enrolled at delivery and information 
about the mother (age, gravidity, obstetric history, length 
of pregnancy, and use of chemoprophylaxis during preg-
nancy) and the newborn (e.g., birthweight) was recorded 
on a standardized questionnaire. Maternal peripheral 
blood, IVS blood, and a biopsy of placental IVS tissue 
were collected.
Laboratory tests
Thick and thin blood smears were prepared of maternal 
peripheral and IVS blood, and impression smears were 
made of biopsied placental tissues. Slides were stained 
with Diff-Quick and slides were read by two microsco-
pists. Capillary tubes were filled with maternal periph-
eral blood and the percent pack cell volume (PCV) 
determined following centrifugation. Placental biopsies 
were fixed in 10% buffered formalin, embedded, stained 
with haematoxylin–eosin, and examined for parasites. 
A woman was considered to be PM positive (PM+) if 
IE were detected in either IVS blood smears, impression 
smears of villous tissue, or histological section of the pla-
centa. Women were considered to PM negative (PM−) if 
parasites were not detected in peripheral and placental 
smears. Women with peripheral parasitaemia, but with-
out placental parasitaemia, were excluded from study. 
Women were considered anemic if they had < 30% PCV, 
as defined by the WHO. Singletons weighing less than 
2500 grams were considered LBW, and those delivered 
between 28 and 37 weeks of gestation were classified as 
being pre-term.
Sample selection
All women with PM (n =  341 PM+) and delivered live 
neonates ≥  28  weeks of gestation were included. For 
comparison, approximately three times of the number 
(n = 1036) of PM− women were randomly selected who 
met the inclusion criteria.
Recombinant proteins
Recombinant proteins used in this study have been 
reported previously [16–18] and included full-length 
FV2 (FCR3 line), DBL1 + 2, ID1-ID2a (the minimal CSA 
binding site of VAR2CSA), individual domains DBL1 
through DBL6 (3D7, 7G8 and FCR3 lines). In addition, 11 
known non-VAR antigens (AMA-1, CSP, EBA-175, LSA1, 
MSP 1, MSP2, MSP3 and MSP11, Pf41, Pf 70 and RESA) 
were tested. Detailed information on the antigens has 
been previously published [26].
Preparing multiplex of recombinant proteins coupled 
to microspheres
The method for coupling recombinant proteins to Sero-
MAP microspheres has been described previously [16, 
27]. In brief, the optimal amount of each protein for satu-
rating 1 million microspheres was covalently coupled to 
beads with different spectral addresses overnight at 4 °C. 
Following blocking with phosphate buffered saline (PBS) 
containing 1% bovine-serum albumin (PBS-1% BSA), 
the microspheres were multiplexed by pooling equal 
numbers of each antigen to create three pools of 9-10 
antigens each. The pools include 1) Multiplex R (9 anti-
gens)—DBL1 (IT4 line), ID1-ID2a (3D7 line), DBL1 + 2 
(FCR3 line), DBL4 (7G8 line), DBL5 (3D7 line), DBL6 
(7G8 line), MSP1, MSP3, MSP11; 2) Multiplex S (10 anti-
gens)—DBL1 (7G8 line), 1D1-ID2a (FCR3 line), DBL2 
(FCR3 line), DBL3 (7G8 line), DBL5 (FCR3 line), DBL6 
(FCR3 line), LSA1, AMA-1, Pf41, RESA; and 3) Multi-
plex T (9 antigens)—FV2 (FCR3 line), DBL1 (3D7 line), 
DBL3 (FCR3 line), DBL4 (FCR3 line), DBL5 (7G8 line), 
CSP, Pf70, EBA-175, MSP2. Seven controls were included 
on each plate: pools of (1) plasma from pregnant Ameri-
can women, (2) Cameroonian males, (3) two dilutions of 
plasma from multigravid Cameroonian women (4 wells) 
and PBS.
Multi‑analyte platform (MAP) assay for IgG Ab
The MAP assay was performed as previously described 
[16, 17, 27]. In brief, 50 µl of each antigen pool (contain-
ing 2000 microspheres of each antigen) were incubated 
with 50 µl of a 1:200 dilution of plasma in PBS-1% BSA 
in pre-wetted filter plates (96 well Multiscreen BV; Mil-
lipore) for 1 h at 25 °C on a rotating shaker at 650 rpm. 
Microspheres were washed twice with PBS-0.05% 
Tween20 and once with PBS-1% BSA. Then, 100  µl of 
secondary Ab [R-phycoerythrin-conjugated, Affini Pure 
F(ab′)2 fragment, goat anti-human IgG Fc fragment-
specific, Jackson Immunoresearch] diluted to 2  µg/ml 
in PBS-1% BSA was added to each well and incubated as 
above in the dark for 1 h. Microspheres were washed as 
described above, re-suspended in 100  µl PBS-1% BSA, 
and the microsphere suspension was analysed using a 
Liquichip M100 reader (Luminex Corp., Austin, TX). 
The reader was programmed to read a minimum 100 
beads per spectral address, DD Gate 7500–15,000 and 
35 s timeout. The results were expressed as median flu-
orescence intensity (MFI). The serological assays were 
repeated twice and the average of the two MFIs was used 
for analysis.
Statistical analysis
Demographic, clinical, and assay variables were first 
summarized using descriptive statistics: means with 
Page 4 of 12Siriwardhana et al. Malar J  (2017) 16:391 
standard deviations (SD) or median with 25th and 75th 
percentiles for continuous variables based on distribu-
tion; frequencies and percentages for categorical vari-
ables, e.g., maternal anaemia status. Two-sample t-tests 
or Wilcoxon-Rank-Sum test for continuous variables 
(based on the distribution) and Chi square tests for cat-
egorical variables were used to compare women with and 
without PM. To help visualize the antibody data, we also 
generated a heatmap, a graphical representation of data, 
along with clustering of antibodies and patients based 
on hierarchical clustering (Additional file  1: Figure S1). 
The associations between the outcome variable, PM sta-
tus, and each of the assay variables were then evaluated 
through univariate logistic regression. The area under the 
Receiver Operating Curve (ROC), or AUC, was calcu-
lated to assess the discrimination power of each variable.
Next, a suitable subset of demographic and biological 
assay variables was determined for the statistical predic-
tive models. The inclusion of highly correlated predictor 
valuables could result in unreliable and unstable estimates 
for a parametric model. The Pearson correlation coeffi-
cients were estimated between pairs of all possible can-
didate predictive variables. Only one variable between 
a pair of candidate predictors was selected into the pro-
posed predictors set, if the estimated Pearson correlation 
coefficient between the pair was larger than a threshold 
value of 0.8. For example, different DBL domains from 
the three P. falciparum lines, 3D7, 7G8, and FCR3, were 
highly associated (see Fig. 1). Therefore, only FCR3 was 
selected for the multivariable model development. Clini-
cal variables with significant amount of missing values 
were not included in the multivariable analysis. A logis-
tic regression model was first fitted for the malaria status 
using the proposed set of candidate predictors by incor-
porating all possible two-way interactions. Next, a step-
wise adding and dropping technique [28] was utilized to 
obtain a reduced model that has a lower Akaike Informa-
tion Criterion (AIC), for better performance and simplic-
ity. Note that, the model that holds the lowest AIC attains 
the highest likelihood integrated with a penalty for the 
Fig. 1 A graphical representation for correlations among antibodies
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number of estimated parameters. The same process was 
also taken using a different model selection criterion, the 
Bayesian Information Criterion (BIC), which resulted in 
the same final model, Performances of proposed multi-
assay logistic models were evaluated on multiple per-
formance measures such as overall prediction accuracy, 
sensitivity, specificity, and AUC. A model that archived 
large values of the above measures can be reasonably 
considered as a “good” model for the binary classification 
problem.
To avoid model overfitting, the classification perfor-
mance was assessed by applying the fivefold cross valida-
tion technique. Initially, the dataset of 1377 individuals 
was partitioned into five approximately equal-sized ran-
dom subgroups or folds. Four of the five folds were used 
for model development, while the remaining fold was 
used as a test set to examine the performance of the clas-
sification. This procedure was repeated 500 times with 
different sets of random partitions to evaluate the aver-
age performance. Here we determine the optimal prob-
ability cut-point for class specification by maximizing the 
Youden’s J statistic, which is a commonly applied tool in 
binary classification problems for optimizing both sensi-
tivity and specificity.
To compare with the above logistic regression 
approach, other classification techniques, i.e., classifiers, 
for developing predictive models were also considered. 
For this purpose, five approaches namely Recursive Parti-
tioning (RPART), Random Forests (RF), Linear Discrimi-
nate Analysis (LDA), Quadratic Discriminant Analysis 
(QDA), and Support Vector Machine (SVM) were con-
sidered [29–34]. These five classifiers were selected due 
to the diverse nature of their underlying techniques.
A classification tree is used for classifying an observa-
tion into a certain class among multiple choices, based 
on the values of predictor variables. The algorithm devel-
ops a tree type structure to discriminate an observation 
based on its characteristics, by determining optimal cut 
points for each predictive variable to specify a class. The 
results are easy to interpret and visualize and can poten-
tially uncover patterns in the data that cannot be easily 
identified through traditional regression methods. The 
recursive partitioning (RPART) [29] is a non-parametric 
multivariable  classification technique that develops a 
decision  tree based on a sequence of logical conditions 
to determine subsets from a sample based  on covariate 
specification. In this way, RPART allows for a data-driven 
exploration of  non-linear  relationships and interactions 
among many explanatory variables. Algorithms given 
by CART and C4.5 are two well-known techniques for 
developing such a classifier [29, 32]. Random forest (RF) 
[31] is another tree based classifier, but it takes an addi-
tional step forward by growing a collection of trees other 
than a single decision tree. RF is developing by using a 
set of bootstrap samples randomly drawn from the origi-
nal data with replacement. About a two-third of data 
that selected from bootstrapping are used to growing 
each classification tree, and the remaining one-third of 
the data called Out-Of-Bag (OOB) are used to obtaining 
unbiased estimates of classification errors and variable 
importance. The predicted class of a new observation 
is determined as the aggregated majority vote by all the 
decision trees.
Linear Discriminate Analysis (LDA) is a classical clas-
sification technique originally proposed for the two 
class classification [30]. Later, this method was general-
ized for the multiclass classification [33]. LDA assumes 
that the class specific attribute variables are multivari-
ate normally distributed with a class specific mean vec-
tor and a common covariance matrix shared between 
classes. Assuming a prior probability for an observation 
to be of a given class, a posterior probability is then cal-
culated, based on observed data. The most appropriate 
class for the observation is determined as the one with 
the highest posterior probability. Quadratic Discriminant 
Analysis (QDA) is the generalized version of LDA, which 
relaxes the assumption of shared covariance matrices. 
Unlike LDA and QDA, Support Vector Machine (SVM) 
is a supervised machine learning algorithm that does not 
use distributional assumptions. It seeks hyper planes in 
a multi-dimensional space of attribute variables that 
specify decision boundaries. For an optimal solution, the 
algorithm determines class boundaries with the maxi-
mum margin of difference. SVM is known to be one of 
the broadly improved classification techniques in recent 
past [34].
In addition to reporting the prediction performance of 
each of the individual classifier, the agreement between 
classification decisions was evaluated with respect to 
the overall prediction, and PM−, PM+ group specific 
predictions, by analysing the proportion of consensus of 
classified cases shared by each pair of classifiers. If two 
classifiers share a large proportion of commonly classi-
fied subjects, it ostensibly reflects a high agreement.
An analysis was conducted to further study the impor-
tance of proposed predictive variables on predicting PM 
for the reduced logistic regression model. The investiga-
tion was performed parallel to the fivefold cross valida-
tion technique, i.e., partitioning the data into five equally 
sized random folds, with four folds for modelling the 
classifier and the remaining fold as a test set. Suppose 
two sets given by Si+ and Si− represent ith covariate val-
ues observed for PM+  and PM− cases, respectively, 
based on whole data. In the test set, ith covariate values 
of PM+ cases were replaced by a sample drawn from Si−, 
using the simple random sampling with replacement. In 
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the same fashion, corresponding covariate values of test 
PM− cases were replaced by a sample drawn from Si+. 
This mechanism allows one to examine the classifier’s 
prediction performances under miss-specified ith predic-
tor. If the overall predictability, sensitivity, or specificity 
changes considerably by the permutation approach, the 
particular variable must be playing an important role 
in specifying PM status. This method was adopted to 
quantify the importance of each proposed predictor, by 
averaging the absolute difference between un-permuted 
and permuted performance measures, using 1500 ran-
dom sets of partitions for each predictor. Based on these 
quantities, rankings of the predictors were calculated 
with respect to each of the four performance measures. 
Finally, a common rank list for the proposed predictors 
was obtained based on the weighted rank aggregation 
concept [35, 36], using the Spearman’s foot-rule distance, 
assuming all four performance measures are equally 
important.
All statistical analyses described were conducted using 
SAS and R statistical software packages. A P value of less 
than 0.05 was considered as statistically significant.
Results
Characteristics of the study sample
The characteristics of the pregnant women and their neo-
nates studied are described in Table 1. Women with PM 
were younger (P  <  0.0001) and had fewer pregnancies 
(P < 0.0001) compared with those without PM. Women 
with PM had a higher prevalence of pre-term deliver-
ies (P  =  0.014), anaemia (P  <  0.0001), and low birth 
weight babies (P  =  0.0011) compared to PM− women. 
PM+ women also had shorter lengths of pregnancy 
(P = 0.0006) and lower birth weight babies (P < 0.0001).
Summary of antibody assay variables between PM+ 
and PM− women
The descriptive statistics of assay variables between PM+ 
and PM− women are shown in Table  2. PM+ women 
recognized more DBL domains (P  <  0.0001) and had 
higher IgG levels to FV2, DBL1 + 2, DBL2, DBL3, DBL4, 
DBL5, DBL6 (all lines, all P < 0.0001) and ID1-ID2a (3D7 
line, P < 0.0001). In addition, women with PM had higher 
IgG levels to AMA-1, CSP, EBA-175, LSA1, MSP1, MSP2, 
MSP3, MSP11, Pf41, Pf70 (all P  <  0.0001) and RESA 
(P  =  0.0095). The predictive accuracy of each variable 
was assessed by determining the AUC using the ROC 
method based on the entire data set. Table 2 summarizes 
the AUCs for individual predictors. The discriminative 
powers of each individual assay were between 55 and 70% 
range. AMA-1 and MSP2 had the best individual predic-
tive performance.
Logistic multi‑assay predictive models
The study hypothesized that a combination of assays 
would improve discriminatory power, as each assay 
would contribute somewhat unique information to a 
predictive model. Two multivariable logistic regressions 
models were generated using demographic variables 
and individual assays with their pairwise interactions. 
A complete logistic regression model (LR-Full) was first 
developed using a set of nineteen individual predictive 
variables and their all possible pairwise interactions. A 
reduced version of it was then developed by utilizing an 
“adding-and-dropping” criteria to achieve a more simpli-
fied model with the minimum AIC value [28]. Figure  2 
illustrates the resulted components along with their sig-
nificance for the reduced logistic regression model (LR-
Reduced). Among nineteen individual predictors used in 
Table 1 Characteristics of pregnant women and their neonates
For variables with missing values indicated by * sign, percentages are calculated by non-missing data
Characteristic PM+ (n = 341) PM− (n = 1036) P‑value
Age in year, mean (SD) 24.3 (5.4) 26.3 (5.8) < 0.0001
Gravidity, mean (SD) 2.7 (1.9) 3.2 (2.1) < 0.0001
Placental parasitaemia by impression smears in  %, mean (SD) 5.4 (12.4) 0 (0) n/a
Clinic location, n (%) 0.59
 BA-all 194 (56.9%) 607 (58.6%)
 CM-NHR 147 (43.1%) 429 (41.4%)
Pre-term delivery, n (%)* 75 (24.2%) 171 (17.8%) 0.014
Length of pregnancy in weeks, mean (SD) 38.3 (3.2) 39.0 (3.0) 0.0006
Intrauterine growth restriction 17 (5.0%) 41 (14.0%) 0.43
Maternal anaemia at delivery, n (%)* 90 (26.4%) 136 (15.3%) < 0.0001
Haematocrit in  %, mean (SD) 31.3 (6.2) 34.9 (5.9) < 0.0001
Low birth weight babies, n (%)* 70 (21.6%) 139 (14.0%) 0.0011
Baby weight in grams, mean (SD) 2922 (656) 3134 (635) < 0.0001
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the model, six variables namely ID1- ID2a (FCR3 line), 
AMA-1, CSP, LSA1, MSP1, and gravidity were reported 
to have significant main effects. Suggesting the poten-
tial complex paths of controlling PM, many associations 
appeared to be significant for the model. For instance, 
a wide set of significant pairwise interactions between 
mothers’ age with other factors were observed.
Comparison of the seven predictive models based on full 
data and cross‑validation
In addition to the two logistic regression models, five 
other classification algorithms (RF, RPART, LDA, QDA, 
and SVM) were also used to develop predictive mod-
els. Prediction performances information of all seven 
classifiers with respect to the four types of performance 
measures are presented in Table 3, both based on the full 
data of 1377 individuals and through cross-validation.
Based on the fivefold cross-validation approach, RF 
holds the highest accuracy approximately 75%, and next 
LR-Reduced with approximately 71% overall accuracy 
in predicting the PM. These two were the best amongst 
all seven classification methods with respect to overall 
accuracy measure. Overall accuracies by other meth-
ods ranged from 45 to 69%. Based on the accuracy of 
predicting protection from PM (PM−, sensitivity), RF 
clearly outperformed all other classifiers, holding about 
90% sensitivity. In general, except LDA and QDA, all 
other classification methods showed reasonably good 
Table 2 Comparisons of antibody levels
The data were summarized by median MFI with 25th and 75th percentiles
AUC was based on univariate logistic regression models
P-value was based on Wilcoxon-Rank-Sum test
Variable PM+ (n = 341) PM− (n = 1036) P‑value AUC
FV2 FCR3 4820 (1360, 11,497) 1427 (426, 5553) < 0.0001 0.66
DBL1 + 2 FCR3 2195 (746, 5944) 829 (277, 3034) < 0.0001 0.65
DBL1 IT4 1261 (421, 3130) 476 (201, 1320) < 0.0001 0.66
DBL1 3D7 1258 (511, 3037) 571 (225, 1433) < 0.0001 0.65
DBL1 7G8 921 (392, 1925) 583 (249, 1250) < 0.0001 0.60
DBL2 FCR3 815 (410, 1737) 526 (189, 1275) < 0.0001 0.60
DBL3 FCR3 1286 (434, 4193) 625 (148, 2334) < 0.0001 0.62
DBL3 7G8 2126 (603, 6850) 717 (201, 3190) < 0.0001 0.65
DBL4 FCR3 2096 (617, 4960) 875 (229, 2757) < 0.0001 0.63
DBL4 7G8 1108 (384, 3383) 451 (161, 1522) < 0.0001 0.64
DBL5 FCR3 7987 (793, 19,534) 1031 (138, 10,278) < 0.0001 0.66
DBL5 3D7 3898 (620, 10,411) 718 (164, 5251) < 0.0001 0.66
DBL5 7G8 4940 (743, 12,478) 686 (178, 6776) < 0.0001 0.66
DBL6 FCR3 1277 (393, 3686) 494 (150, 1648) < 0.0001 0.64
DBL6 7G8 4389 (1766, 9280) 2274 (793, 5222) < 0.0001 0.64
ID1-ID2a FCR3 474 (212, 1475) 304 (120, 773) < 0.0001 0.61
ID1-ID2a 3D7 2089 (884, 3952) 1356 (490, 3243) < 0.0001 0.58
Number of domain recognized out of 6 2 (0, 3) 0 (0, 2) < 0.0001 0.64
Number of variants recognized out of 13 3 (0, 6) 0 (0, 4) < 0.0001 0.65
AMA-1 23,769 (17,479, 24,375) 14,621 (3597, 23,680) < 0.0001 0.70
CSP 398 (193, 891) 231 (137, 545) < 0.0001 0.62
EBA-175 17,755 (4388, 24,143) 5263 (731, 20,562) < 0.0001 0.66
LSA1 452 (158, 1833) 190 (71, 736) < 0.0001 0.63
MSP1 4851 (1045, 13,335) 1856 (450, 8148) < 0.0001 0.61
MSP2 11,432 (3751, 22,159) 3303 (805, 10,511) < 0.0001 0.69
MSP3 1069 (362, 4188) 413 (149, 1853) < 0.0001 0.63
MSP11 1629 (629, 4031) 681 (298, 1789) < 0.0001 0.66
Pf41 5214 (809, 17,004) 1654 (239, 8324) < 0.0001 0.63
Pf70 815 (470, 1478) 602 (294, 1093) < 0.0001 0.60
RESA 84 (49, 228) 73 (43, 179) 0.0095 0.55
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performance on the sensitivity. Although RF had a better 
performance in terms of overall accuracy and the sensi-
tivity, it had the worst performance on (i.e., about 30%) 
predicting infection of PM (PM+, specificity). LDA and 
LR-Reduced were the top two classifiers with respect 
to the specificity. For a binary classifier, higher values 
of AUC reflect its balanced performance accounting 
for both sensitivity and specificity. Calculated AUC’s of 
seven classifiers ranged from 64 to 76% with LR-Reduced 
being the best. Considering the overall performance 
assessment by AUC, the LR-Reduced is recommended 
as the most appropriate classifier for predicting PM, on 
the proposed set of demographic and biological predic-
tors. This model holds reasonably good sensitivity and 
specificity measures. Although LR-Reduced model that 
had approximately 0.76 AUC, we noticed that the AUC 
for AMA-1 alone using the univariate logistic regression 
models was as high as 0.7. Therefore, extensive prediction 
performance boost by the multivariate approach was not 
observed as hypothesized.
Agreement of classifiers
These classifiers’ predictions were further investigated by 
evaluating the agreement on their classification decisions. 
As shown in Table  4, from the prospect of overall clas-
sification, consensus decisions among classifiers ranged 
from 42 to 86%, reflecting diverse prediction attributes. 
Similar results were observed for PM− and PM+ predic-
tion cases. Approximately consensus decisions rates were 
changed from 89 to 41 and 77 to 44%, respectively for 
PM− and PM+ predictions.
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ID1-ID2a FCR3 0.005 0.098 0.043 <0.001 0.034 0.006
AMA-1 <0.001 0.139 0.003 0.008
CSP 0.005 0.015 0.004 0.054 0.039 0.101 0.048
EBA-175 0.102 0.098 0.108 0.022 0.016 0.145 0.070
LSA1 0.019
MSP1 <0.001
MSP2 0.053
MSP3 0.481
MSP11 0.175 0.065
Pf41 0.686 0.102
Pf70 0.058 0.039
RESA 0.435
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Fig. 2 A graphical representation of individual predictors and interactions included in the final logistic regression (LR-Reduced) model. First column 
indicates predictor’s main effect significance and remaining columns presents the pairwise interactions integrated in the model along with signifi-
cance. Note that interactions are presented only once
Table 3 Prediction performances of  seven classifiers 
on discriminating PM+ and PM−, evaluated using the five-
fold cross validation technique and full data
LR-Full Logistic Regression Full model, LR-Reduced Logistic Regression 
Reduced model, RPART Recursive Partitioning, RF Random Forests, LDA Linear 
Discriminant Analysis, QDA Quadratic Discriminant Analysis, SVM Support Vector 
Machine
Classifier Overall Accuracy Specificity Sensitivity AUC
LR-Full 0.68 0.51 0.73 0.64
LR-Reduced 0.71 0.66 0.73 0.76
RPART 0.69 0.54 0.74 0.67
RF 0.75 0.30 0.90 0.74
LDA 0.45 0.82 0.33 0.73
QDA 0.49 0.63 0.46 0.71
SVM 0.51 0.42 0.83 0.69
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Importance of variables in prediction performance
Based on the permutation approach described in the 
methods section, the importance of each variable of 
the LR-Reduced model in each performance measure 
is summarized in Table  5. This includes absolute devia-
tions calculated between before and after permuting each 
candidate predictor and corresponding rankings with 
respect to performance. Here, larger values of absolute 
deviation indicate crucial variables upon the specific per-
formance measure used. For example, MSP2, AMA-1, 
EBA-175, MSP11, and ID1-ID2a (FCR3) were the top five 
important predictors that have an impact on the accu-
racy of correctly detecting PM+ cases. Based on the rank 
aggregation [35, 36] over all four performance measures, 
the top five important antibodies affecting the prediction 
performance were identified as AMA-1, MSP2, EBA-175, 
Pf41, and MSP11.
Discussion
To our knowledge, this is the first comprehensive step 
towards the identification of correlates of protection for 
PM using a multi-assay approach. Different combina-
tions of immunological assays measuring immunity to 
VAR2CSA and non-pregnancy antigens in PM+ and 
PM− Cameroonian women were used to derive the best 
predicted model. The principal findings are that multiple 
assays can lead to improved power compared to the uni-
variable approach using a single assay.
In the construction of multivariable logistic regres-
sion models, a larger model that included a set of nine-
teen potential demographic and biological predictors 
and their pairwise interactions was first estimated. Then, 
a final reduced model was determined using a stepwise 
approach. The final model demonstrated a moderate 
improvement in predicting the PM status given mothers’ 
Table 4 Agreements among seven classifiers discriminating an individual, evaluated using the fivefold cross validation 
technique
Based on (a). overall classification, (b). PM− classification, and (c). PM+ classification
LR‑Full LR‑Reduced RPART RF LDA QDA SVM
LR-Full
 (a) 1.00 0.85 0.76 0.73 0.53 0.51 0.71
 (b) 1.00 0.87 0.79 0.77 0.52 0.51 0.74
 (c) 1.00 0.77 0.66 0.63 0.58 0.53 0.62
LR-Reduced
 (a) 0.85 1.00 0.76 0.72 0.57 0.53 0.73
 (b) 0.87 1.00 0.79 0.77 0.53 0.52 0.75
 (c) 0.77 1.00 0.67 0.58 0.70 0.58 0.65
RPART
 (a) 0.76 0.76 1.00 0.86 0.49 0.50 0.76
 (b) 0.79 0.79 1.00 0.89 0.48 0.49 0.80
 (c) 0.66 0.67 1.00 0.77 0.54 0.51 0.64
RF
 (a) 0.73 0.72 0.86 1.00 0.42 0.47 0.76
 (b) 0.77 0.77 0.89 1.00 0.41 0.47 0.80
 (c) 0.63 0.58 0.77 1.00 0.44 0.47 0.64
LDA
 (a) 0.53 0.57 0.49 0.42 1.00 0.82 0.54
 (b) 0.52 0.53 0.48 0.41 1.00 0.84 0.52
 (c) 0.58 0.70 0.54 0.44 1.00 0.74 0.61
QDA
 (a) 0.51 0.53 0.50 0.47 0.82 1.00 0.52
 (b) 0.51 0.52 0.49 0.47 0.84 1.00 0.51
 (c) 0.53 0.58 0.51 0.47 0.74 1.00 0.55
SVM
 (a) 0.71 0.73 0.76 0.76 0.54 0.52 1.00
 (b) 0.74 0.75 0.80 0.80 0.52 0.51 1.00
 (c) 0.62 0.65 0.64 0.64 0.61 0.55 1.00
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information, compared to the univariable approach, 
indicating the advantages of utilizing multiple predic-
tors as outlined in objectives of this study. As alterna-
tives to the logistic regression approach, five other types 
of commonly used classifications techniques were con-
sidered. Several comparative studies evaluating classifi-
ers performances showed diverse predictive capabilities 
with respect multiple performance measures. When the 
global performances of classifiers were considered across 
multiple attributes such as overall accuracy, sensitivity, 
specificity, and AUC, the logistic regression approach 
can be reasonably considered the best for this classifica-
tion problem. In addition to developing predictive mod-
els, a permutational method was applied to examine the 
importance of each predictive variable for the reduced 
logistic regression model, upon different attributes. This 
technique is a general concept that can be applied to any 
parametric or nonparametric classifier in finding rank-
ings of importance of predictors. Furthermore, the top 
five ranked predictors that are crucial on all four attrib-
utes considered were identified.
Since antibody responses data generally follow a 
highly-skewed distribution, the classifiers were also 
trained using the log transformed antibody data, con-
sidering that such approach may improve the robustness 
of parameter estimates by diminishing the effects of 
extreme data points. However, generally, the prediction 
performance was low with this approach. In addition, the 
impact of adding second order polynomials of antibod-
ies was also evaluated comparing with the corresponding 
univariate models, but the predictive performances were 
not largely improved. There are several potential limita-
tions of the current study. The true nature of the natural 
acquisition of immunity to placental malaria during the 
pregnancy is unclear without longitudinal data. No suf-
ficient information is available to evaluate the influence 
of HLA on the current study, but based on available data 
and that the women had similar ethnic backgrounds, the 
influence is likely to be minimal. It is likely that women in 
the study were infected several times during pregnancy, 
as the samples were collected at the time of delivery. 
Selection of the threshold value for the maximum cor-
relation allowed between pairs of predictors was based 
on the general consideration of minimizing the multicol-
linearity. A separate test set was not used for validation, 
but  instead utilized the standard K-cross validation (i.e., 
with K = 5) technique to evaluate the performance of a 
classifier, which provides an unbiased estimate of perfor-
mance measures compared to the conventional approach 
that uses a single fixed test set. The averaging via many 
random folds removes the biasedness that could cause 
by the partition(s) selection. It is also important to note 
that, the use of an independent test set that comes from 
an entirely a different population than the study popula-
tion may provide a strong evidence for a validation, but 
such data with the exact same measurements measured 
in a substantially large number of subjects with similar 
inclusion criteria was not available for an extensive study. 
Although the permutational approach is a sensible way of 
examining the importance of predictors, one can follow 
any other suitable alternatives based on his/her objec-
tives. When the rank aggregation approach was applied 
to determine a commonly important set of predictors, 
all four performance measures were equally prioritized, 
which can be also conducted with different weights for 
each performance measures using a reasonable weight-
ing criterion. Despite these limitations, the current study 
demonstrated the potential utility of incorporating multi-
ple malarial antigens in developing predictive models for 
PM states.
Predictive models use data to find associations between 
a specific outcome, in this case presence/absence of PM 
at delivery, and other host and immune parameters, but 
do not always identify factors involved in protection. In 
this study, the top five important variables affecting pre-
diction performance were having Ab to the non-VAR 
antigens, AMA-1, MSP2, EBA-175, Pf41, and MSP11. 
The results suggest that Ab to key merozoite antigens are 
Table 5 Absolute deviations between  overall accuracies 
reported for  un-permuted and  permuted cases, by  each 
predictor variable for the final logistic model (LR-Reduced)
Values inside brackets provide ranks of each variable. Rank one is given to the 
variable with the highest absolute deviation
Predictor Overall accu‑
racy
Specificity Sensitivity AUC
Age 0.001 (18) 0.001 (18) 0.002 (15) <0.001 (19)
Gravidity 0.002 (17) 0.001 (19) 0.002 (14) 0.003 (13)
FV2 FCR3 0.007 (08) 0.011 (06) 0.005 (11) 0.006 (09)
DBL2 FCR3 0.003 (13) 0.008 (10) 0.001 (18) 0.009 (06)
DBL3 FCR3 0.002 (15) 0.007 (11) 0.001 (16) 0.002 (14)
DBL4 FCR3 0.007 (07) 0.007 (12) 0.007 (08) 0.001 (17)
DBL6 FCR3 0.012 (05) 0.009 (09) 0.013 (05) 0.009 (07)
ID1-ID2a FCR3 0.005 (09) 0.011 (05) 0.004 (12) 0.001 (16)
AMA-1 0.036 (01) 0.028 (02) 0.039 (01) 0.032 (01)
CSP 0.003 (14) 0.010 (08) 0.001 (17) 0.003 (12)
EBA-175 0.017 (02) 0.018 (03) 0.017 (02) 0.019 (03)
LSA1 0.005 (11) 0.002 (17) 0.006 (10) 0.001 (18)
MSP1 0.005 (12) 0.003 (15) 0.007 (07) 0.002 (15)
MSP2 0.017 (03) 0.029 (01) 0.013 (04) 0.021 (02)
MSP3 <0.001 (19) 0.004 (13) <0.001 (19) 0.004 (11)
MSP11 0.010 (06) 0.013 (04) 0.009 (06) 0.011 (05)
Pf41 0.014 (04) 0.010 (07) 0.016 (03) 0.011 (04)
Pf70 0.002 (16) 0.004 (14) 0.002 (13) 0.004 (10)
RESA 0.005 (10) 0.003 (16) 0.006 (09) 0.007(08)
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important, which is logical, since a previous study con-
ducted in Yaoundé found that half of women who were 
malaria-positive during the second trimester lacked Ab 
to FV2 at delivery, but were PM−. Thus, Ab to antigens 
other than VAR2CSA appear to be important in eliminat-
ing PM. Overall, the key predictors identified using the 
modeling approach are logical.
Conclusion
Improved discrimination ability of PM status compared 
to individual assays was observed when multiple malar-
ial antigens were considered together. Based on a com-
parison study, the reduced logistic regression approach 
was found to have the overall best predictive quality 
with respect to multiple performance measures, com-
pared with several other commonly used classification 
approaches for developing predictive models. Addition-
ally, the antigens’ impact on multiple performance meas-
ures in the final model was quantified and the top PM 
status predictors were identified as AMA-1, MSP2, EBA-
175, Pf41, and MSP11.
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